BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vainer B, Nielsen OH. Changed colonic profile of P-selectin, platelet-endothelial cell adhesion molecule-1 (PECAM-1), intercellular adhesion molecule-1 (ICAM-1), ICAM-2, and ICAM-3 in inflammatory bowel disease. Clin Exp Immunol. 2000;121:242-247. [PMID: 10931137 DOI: 10.1046/j.1365-2249.2000.01296.x] [Cited by in Crossref: 60] [Cited by in F6Publishing: 66] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Wanchaitanawong W, Thinrungroj N, Chattipakorn SC, Chattipakorn N, Shinlapawittayatorn K. Repurposing metformin as a potential treatment for inflammatory bowel disease: Evidence from cell to the clinic. Int Immunopharmacol 2022;112:109230. [PMID: 36099786 DOI: 10.1016/j.intimp.2022.109230] [Reference Citation Analysis]
2 Fu X, Wang J, Cai H, Jiang H, Han S. C16 Peptide and Ang-1 Improve Functional Disability and Pathological Changes in an Alzheimer’s Disease Model Associated with Vascular Dysfunction. Pharmaceuticals 2022;15:471. [DOI: 10.3390/ph15040471] [Reference Citation Analysis]
3 Maheshwari A, Mezu-ndubuisi OJ. Role of the Endothelium in Neonatal Diseases. Newborn 2022;1:44-57. [DOI: 10.5005/jp-journals-11002-0025] [Reference Citation Analysis]
4 Mitselou A, Grammeniatis V, Varouktsi A, Papadatos SS, Klaroudas A, Katsanos K, Galani V. Immunohistochemical Study of Adhesion Molecules in Irritable Bowel Syndrome: A Comparison to Inflammatory Bowel Diseases. Adv Biomed Res 2021;10:21. [PMID: 34703800 DOI: 10.4103/abr.abr_2_20] [Reference Citation Analysis]
5 Zhao ML, Chen T, Zhang TH, Tian F, Wan X. H19 Overexpression Improved Efficacy of Mesenchymal Stem Cells in Ulcerative Colitis by Modulating the miR-141/ICAM-1 and miR-139/CXCR4 Axes. Dis Markers 2021;2021:7107705. [PMID: 34630738 DOI: 10.1155/2021/7107705] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
6 Wiendl M, Becker E, Müller TM, Voskens CJ, Neurath MF, Zundler S. Targeting Immune Cell Trafficking - Insights From Research Models and Implications for Future IBD Therapy. Front Immunol 2021;12:656452. [PMID: 34017333 DOI: 10.3389/fimmu.2021.656452] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
7 Marafini I, Monteleone G. Therapeutic Oligonucleotides for Patients with Inflammatory Bowel Diseases. Biologics 2020;14:47-51. [PMID: 32606588 DOI: 10.2147/BTT.S257638] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
8 Sakisaka H, Takedatsu H, Mitsuyama K, Mochizuki S, Sakurai K, Sakisaka S, Hirai F. Topical Therapy with Antisense Tumor Necrosis Factor Alpha Using Novel β-Glucan-Based Drug Delivery System Ameliorates Intestinal Inflammation. Int J Mol Sci 2020;21:E683. [PMID: 31968666 DOI: 10.3390/ijms21020683] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
9 Mietani K, Sumitani M, Ogata T, Shimojo N, Inoue R, Abe H, Kawamura G, Yamada Y. Dysfunction of the blood-brain barrier in postoperative delirium patients, referring to the axonal damage biomarker phosphorylated neurofilament heavy subunit. PLoS One 2019;14:e0222721. [PMID: 31574089 DOI: 10.1371/journal.pone.0222721] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
10 Potdar AA, Li D, Haritunians T, VanDussen KL, Fiorino MF, Liu TC, Stappenbeck TS, Fleshner P, Targan SR, McGovern DPB, Bilsborough J. Ileal Gene Expression Data from Crohn's Disease Small Bowel Resections Indicate Distinct Clinical Subgroups. J Crohns Colitis 2019;13:1055-66. [PMID: 30877309 DOI: 10.1093/ecco-jcc/jjz021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
11 Yan Y, Wang P, Sun Y, Dong Y, Xing J. Potential Mechanisms of 3, 4-Oxo-Isopropylidene-Shikimic Acid in Ameliorating 2, 4, 6-Trinitrobenzenesulfonic Acid-Induced Colitis in Rats. J Interferon Cytokine Res 2019;39:554-63. [PMID: 31120312 DOI: 10.1089/jir.2019.0064] [Reference Citation Analysis]
12 Scarozza P, Schmitt H, Monteleone G, Neurath MF, Atreya R. Oligonucleotides-A Novel Promising Therapeutic Option for IBD. Front Pharmacol 2019;10:314. [PMID: 31068803 DOI: 10.3389/fphar.2019.00314] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
13 Cheng B, Liang X, Wen Y, Li P, Zhang L, Ma M, Cheng S, Du Y, Liu L, Ding M, Zhao Y, Zhang F. Integrative analysis of transcriptome‐wide association study data and messenger RNA expression profiles identified candidate genes and pathways for inflammatory bowel disease. J Cell Biochem 2019;120:14831-7. [DOI: 10.1002/jcb.28744] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
14 Di Fusco D, Dinallo V, Marafini I, Figliuzzi MM, Romano B, Monteleone G. Antisense Oligonucleotide: Basic Concepts and Therapeutic Application in Inflammatory Bowel Disease. Front Pharmacol 2019;10:305. [PMID: 30983999 DOI: 10.3389/fphar.2019.00305] [Cited by in Crossref: 40] [Cited by in F6Publishing: 45] [Article Influence: 10.0] [Reference Citation Analysis]
15 Bevivino G, Sedda S, Marafini I, Monteleone G. Oligonucleotide-Based Therapies for Inflammatory Bowel Disease. BioDrugs 2018;32:331-8. [PMID: 29948918 DOI: 10.1007/s40259-018-0286-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
16 Reinisch W, Hung K, Hassan-Zahraee M, Cataldi F. Targeting Endothelial Ligands: ICAM-1/alicaforsen, MAdCAM-1. J Crohns Colitis 2018;12:S669-77. [PMID: 29757363 DOI: 10.1093/ecco-jcc/jjy059] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
17 Marafini I, Monteleone G. Inflammatory bowel disease: new therapies from antisense oligonucleotides. Ann Med 2018;50:361-70. [PMID: 29911450 DOI: 10.1080/07853890.2018.1490025] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
18 Greuter T, Vavricka SR, Biedermann L, Pilz J, Borovicka J, Seibold F, Sauter B, Rogler G. Alicaforsen, an Antisense Inhibitor of Intercellular Adhesion Molecule-1, in the Treatment for Left-Sided Ulcerative Colitis and Ulcerative Proctitis. Dig Dis 2018;36:123-9. [PMID: 29207381 DOI: 10.1159/000484979] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
19 Trzeciak-Jędrzejczyk A, Makosiej R, Kolejwa M, Głowacka E, Czkwianianc E. The role of adhesion molecules in inflammatory bowel disease in children. Assessment of the possible risk of cardiovascular complications. Prz Gastroenterol 2017;12:181-5. [PMID: 29123578 DOI: 10.5114/pg.2017.70480] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
20 Jairath V, Khanna R, Feagan BG. Alicaforsen for the treatment of inflammatory bowel disease. Expert Opin Investig Drugs 2017;26:991-7. [PMID: 28670932 DOI: 10.1080/13543784.2017.1349753] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
21 Lasitschka F, Giese T, Paparella M, Kurzhals SR, Wabnitz G, Jacob K, Gras J, Bode KA, Heninger AK, Sziskzai T, Samstag Y, Leszinski C, Jocher B, Al-Saeedi M, Meuer SC, Schröder-Braunstein J. Human monocytes downregulate innate response receptors following exposure to the microbial metabolite n-butyrate. Immun Inflamm Dis 2017;5:480-92. [PMID: 28681454 DOI: 10.1002/iid3.184] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
22 Gu P, Theiss A, Han J, Feagins LA. Increased Cell Adhesion Molecules, PECAM-1, ICAM-3, or VCAM-1, Predict Increased Risk for Flare in Patients With Quiescent Inflammatory Bowel Disease. J Clin Gastroenterol 2017;51:522-7. [PMID: 27552332 DOI: 10.1097/MCG.0000000000000618] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
23 Zhuang P, Wan Y, Geng S, He Y, Feng B, Ye Z, Zhou D, Li D, Wei H, Li H, Zhang Y, Ju A. Salvianolic Acids for Injection (SAFI) suppresses inflammatory responses in activated microglia to attenuate brain damage in focal cerebral ischemia. Journal of Ethnopharmacology 2017;198:194-204. [DOI: 10.1016/j.jep.2016.11.052] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
24 Lin TY, Chen YG, Lin CL, Huang WS, Kao CH. Inflammatory Bowel Disease Increases the Risk of Peripheral Arterial Disease: A Nationwide Cohort Study. Medicine (Baltimore). 2015;94:e2381. [PMID: 26717386 DOI: 10.1097/md.0000000000002381] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
25 Slattery E, Seres DS. Major Infections and Sepsis. Nutrition Support for the Critically Ill 2016. [DOI: 10.1007/978-3-319-21831-1_9] [Reference Citation Analysis]
26 Kim B, Nam S, Lim JH, Lim JS. NDRG2 Expression Decreases Tumor-Induced Osteoclast Differentiation by Down-regulating ICAM1 in Breast Cancer Cells. Biomol Ther (Seoul) 2016;24:9-18. [PMID: 26759696 DOI: 10.4062/biomolther.2015.105] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
27 Angiari S. Selectin-mediated leukocyte trafficking during the development of autoimmune disease. Autoimmunity Reviews 2015;14:984-95. [DOI: 10.1016/j.autrev.2015.06.006] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
28 Tsai MS, Lin CL, Chen HP, Lee PH, Sung FC, Kao CH. Long-term risk of mesenteric ischemia in patients with inflammatory bowel disease: a 13-year nationwide cohort study in an Asian population. Am J Surg 2015;210:80-6. [PMID: 25457233 DOI: 10.1016/j.amjsurg.2014.08.026] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
29 Cui L, Feng L, Zhang ZH, Jia XB. The anti-inflammation effect of baicalin on experimental colitis through inhibiting TLR4/NF-κB pathway activation. Int Immunopharmacol 2014;23:294-303. [PMID: 25239813 DOI: 10.1016/j.intimp.2014.09.005] [Cited by in Crossref: 111] [Cited by in F6Publishing: 120] [Article Influence: 12.3] [Reference Citation Analysis]
30 Silva RA, Almeida FM, Olivo CR, Saraiva-romanholo BM, Martins MA, Carvalho CRF. Airway remodeling is reversed by aerobic training in a murine model of chronic asthma: Exercise decreases lung structural changes. Scand J Med Sci Sports 2015;25:e258-66. [DOI: 10.1111/sms.12311] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
31 Alasehirli B, Oğuz E, Oksuzler E, Koruk I, Oztuzcu S, Ozkara E, Karakok M, Erbagcı AB, Demiryurek AT. Investigation of intercellular adhesion molecules (ICAMs) gene expressions in patients with Barrett's esophagus. Tumour Biol 2014;35:4907-12. [PMID: 24474251 DOI: 10.1007/s13277-014-1644-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
32 Lecce L, Lindsay L, Kaneko Y, Murphy CR. ICAM-2 and lipid rafts disappear from the basal plasma membrane of uterine epithelial cells during early pregnancy in rats. Cell Tissue Res 2013;353:563-73. [DOI: 10.1007/s00441-013-1656-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
33 Taylor KD, Yang H, Rotter JI. Inflammatory Bowel Disease. Emery and Rimoin's Principles and Practice of Medical Genetics 2013. [DOI: 10.1016/b978-0-12-383834-6.00072-0] [Reference Citation Analysis]
34 Mohan M, Kaushal D, Aye PP, Alvarez X, Veazey RS, Lackner AA. Focused examination of the intestinal lamina propria yields greater molecular insight into mechanisms underlying SIV induced immune dysfunction. PLoS One 2012;7:e34561. [PMID: 22511950 DOI: 10.1371/journal.pone.0034561] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
35 Vainer B. Intercellular adhesion molecule-1 (ICAM-1) in ulcerative colitis: presence, visualization, and significance. APMIS Suppl 2010;:1-43. [PMID: 20653648 DOI: 10.1111/j.1600-0463.2010.02647.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
36 Heiligenhaus A, Thurau S, Hennig M, Grajewski RS, Wildner G. Anti-inflammatory treatment of uveitis with biologicals: new treatment options that reflect pathogenetic knowledge of the disease. Graefes Arch Clin Exp Ophthalmol 2010;248:1531-51. [PMID: 20737162 DOI: 10.1007/s00417-010-1485-8] [Cited by in Crossref: 32] [Cited by in F6Publishing: 26] [Article Influence: 2.5] [Reference Citation Analysis]
37 Philpott JR, Miner PB Jr. Antisense inhibition of ICAM-1 expression as therapy provides insight into basic inflammatory pathways through early experiences in IBD. Expert Opin Biol Ther. 2008;8:1627-1632. [PMID: 18774928 DOI: 10.1517/14712598.8.10.1627] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.2] [Reference Citation Analysis]
38 Tsiolakidou G, Koutroubakis IE, Tzardi M, Kouroumalis EA. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease. Dig Liver Dis 2008;40:673-9. [PMID: 18374637 DOI: 10.1016/j.dld.2008.02.010] [Cited by in Crossref: 30] [Cited by in F6Publishing: 34] [Article Influence: 2.0] [Reference Citation Analysis]
39 Deban L, Correale C, Vetrano S, Malesci A, Danese S. Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a Jack of all trades. Am J Pathol. 2008;172:1457-1466. [PMID: 18458096 DOI: 10.2353/ajpath.2008.070593] [Cited by in Crossref: 90] [Cited by in F6Publishing: 99] [Article Influence: 6.0] [Reference Citation Analysis]
40 Deban L, Correale C, Vetrano S, Malesci A, Danese S. Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a Jack of all trades. Am J Pathol. 2008;172:1457-1466. [PMID: 18458096 DOI: 10.2353/ajpath.2008070593] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
41 Chidlow JH Jr, Shukla D, Grisham MB, Kevil CG. Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues. Am J Physiol Gastrointest Liver Physiol 2007;293:G5-G18. [PMID: 17463183 DOI: 10.1152/ajpgi.00107.2007] [Cited by in Crossref: 113] [Cited by in F6Publishing: 119] [Article Influence: 7.1] [Reference Citation Analysis]
42 Taylor KD, Rotter JI, Huiying Y. Genetics of inflammatory bowel disease. Inflammatory Bowel Disease: From Bench to Bedside. [DOI: 10.1007/0-387-25808-6_3] [Reference Citation Analysis]
43 Brittan M, Wright NA. Adult Stem Cells in Normal Gastrointestinal Function and Inflammatory Disease. Principles of Tissue Engineering 2007. [DOI: 10.1016/b978-012370615-7/50049-4] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
44 Yuan H, Ji WS, Wu KX, Jiao JX, Sun LH, Feng YT. Anti-inflammatory effect of Diammonium Glycyrrhizinate in a rat model of ulcerative colitis. World J Gastroenterol 2006; 12(28): 4578-4581 [PMID: 16874877 DOI: 10.3748/wjg.v12.i28.4578] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 61] [Article Influence: 3.3] [Reference Citation Analysis]
45 Koutroubakis IE, Tsiolakidou G, Karmiris K, Kouroumalis EA. Role of angiogenesis in inflammatory bowel disease. Inflamm Bowel Dis 2006;12:515-23. [PMID: 16775497 DOI: 10.1097/00054725-200606000-00012] [Cited by in Crossref: 85] [Cited by in F6Publishing: 78] [Article Influence: 5.0] [Reference Citation Analysis]
46 Miner PB Jr, Geary RS, Matson J, Chuang E, Xia S, Baker BF, Wedel MK. Bioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitis. Aliment Pharmacol Ther 2006;23:1427-34. [PMID: 16669957 DOI: 10.1111/j.1365-2036.2006.02909.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 2.4] [Reference Citation Analysis]
47 van Deventer SJ, Wedel MK, Baker BF, Xia S, Chuang E, Miner PB Jr. A phase II dose ranging, double-blind, placebo-controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left-sided ulcerative colitis. Aliment Pharmacol Ther 2006;23:1415-25. [PMID: 16669956 DOI: 10.1111/j.1365-2036.2006.02910.x] [Cited by in Crossref: 97] [Cited by in F6Publishing: 87] [Article Influence: 5.7] [Reference Citation Analysis]
48 Miner PB Jr, Wedel MK, Xia S, Baker BF. Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left-sided ulcerative colitis: a randomized, double-blind, active-controlled trial. Aliment Pharmacol Ther 2006;23:1403-13. [PMID: 16669955 DOI: 10.1111/j.1365-2036.2006.02837.x] [Cited by in Crossref: 84] [Cited by in F6Publishing: 76] [Article Influence: 4.9] [Reference Citation Analysis]
49 Bardin N, Reumaux D, Geboes K, Colombel JF, Blot-Chabaud M, Sampol J, Duthilleul P, Dignat-George F. Increased expression of CD146, a new marker of the endothelial junction in active inflammatory bowel disease. Inflamm Bowel Dis 2006;12:16-21. [PMID: 16374253 DOI: 10.1097/01.mib.0000194181.46930.88] [Cited by in Crossref: 54] [Cited by in F6Publishing: 53] [Article Influence: 3.2] [Reference Citation Analysis]
50 Miller SJ, Zaloga GP, Hoggatt AM, Labarrere C, Faulk WP. Short-chain fatty acids modulate gene expression for vascular endothelial cell adhesion molecules. Nutrition 2005;21:740-8. [PMID: 15925300 DOI: 10.1016/j.nut.2004.11.011] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 2.5] [Reference Citation Analysis]
51 Ko JKS, Lam FYL, Cheung APL. Amelioration of experimental colitis by Astragalus membranaceus through anti-oxidation and inhibition of adhesion molecule synthesis. World J Gastroenterol 2005; 11(37): 5787-5794 [PMID: 16270386 DOI: 10.3748/wjg.v11.i37.5787] [Cited by in CrossRef: 54] [Cited by in F6Publishing: 57] [Article Influence: 3.0] [Reference Citation Analysis]
52 Brittan M, Chance V, Elia G, Poulsom R, Alison MR, MacDonald TT, Wright NA. A regenerative role for bone marrow following experimental colitis: contribution to neovasculogenesis and myofibroblasts. Gastroenterology 2005;128:1984-95. [PMID: 15940631 DOI: 10.1053/j.gastro.2005.03.028] [Cited by in Crossref: 105] [Cited by in F6Publishing: 112] [Article Influence: 5.8] [Reference Citation Analysis]
53 Tsoutsou PG, Gourgoulianis KI, Petinaki E, Mpaka M, Efremidou S, Maniatis A, Molyvdas PA. ICAM-1, ICAM-2 and ICAM-3 in the Sera of Patients with Idiopathic Pulmonary Fibrosis. Inflammation 2004;28:359-64. [DOI: 10.1007/s10753-004-6647-6] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.1] [Reference Citation Analysis]
54 van Deventer SJ, Tami JA, Wedel MK. A randomised, controlled, double blind, escalating dose study of alicaforsen enema in active ulcerative colitis. Gut 2004;53:1646-51. [PMID: 15479686 DOI: 10.1136/gut.2003.036160] [Cited by in Crossref: 116] [Cited by in F6Publishing: 95] [Article Influence: 6.1] [Reference Citation Analysis]
55 Vainer B, Sørensen S, Seidelin J, Nielsen OH, Horn T. Expression of ICAM-1 in colon epithelial cells: an ultrastructural study performed on in vivo and in vitro models. Virchows Arch. 2003;443:774-781. [PMID: 14564519 DOI: 10.1007/s00428-003-0900-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
56 Ala A, Dhillon AP, Hodgson HJ. Role of cell adhesion molecules in leukocyte recruitment in the liver and gut. Int J Exp Pathol. 2003;84:1-16. [PMID: 12694483 DOI: 10.1046/j.1365-2613.2003.00235.x] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 2.9] [Reference Citation Analysis]
57 Egarter C, Sator M, Huber J. Effects of tibolone on cell adhesion molecules in postmenopausal women: . Menopause 2003;10:218-21. [DOI: 10.1097/00042192-200310030-00008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
58 Vainer B, Nielsen OH. Correlation between circulating soluble ICAM-1 and prednisolone-induced amelioration of ulcerative colitis. Scand J Gastroenterol 2003;38:283-7. [PMID: 12737443 DOI: 10.1080/00365520310000609a] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
59 Li JH, Yu JP, He XF, Xu XM. Expression of NF-kB in rats with TNBS-induced ulcerative colitis. Shijie Huaren Xiaohua Zazhi 2003; 11(2): 214-218 [DOI: 10.11569/wcjd.v11.i2.214] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
60 Taylor KD, Rotter JI, Yang H. Genetics of inflammatory bowel disease. Inflammatory Bowel Disease: From Bench to Bedside 2003. [DOI: 10.1007/978-1-4020-3477-0_3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
61 Yacyshyn BR, Barish C, Goff J, Dalke D, Gaspari M, Yu R, Tami J, Dorr FA, Sewell KL. Dose ranging pharmacokinetic trial of high-dose alicaforsen (intercellular adhesion molecule-1 antisense oligodeoxynucleotide) (ISIS 2302) in active Crohn's disease. Aliment Pharmacol Ther 2002;16:1761-70. [PMID: 12269969 DOI: 10.1046/j.1365-2036.2002.01341.x] [Cited by in Crossref: 56] [Cited by in F6Publishing: 47] [Article Influence: 2.7] [Reference Citation Analysis]
62 Bowen-Yacyshyn MB, Bennett CF, Nation N, Rayner D, Yacyshyn BR. Amelioration of chronic and spontaneous intestinal inflammation with an antisense oligonucleotide (ISIS 9125) to intracellular adhesion molecule-1 in the HLA-B27/beta2 microglobulin transgenic rat model. J Pharmacol Exp Ther 2002;302:908-17. [PMID: 12183646 DOI: 10.1124/jpet.102.036053] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
63 Yacyshyn BR, Chey WY, Goff J, Salzberg B, Baerg R, Buchman AL, Tami J, Yu R, Gibiansky E, Shanahan WR; ISIS 2302-CS9 Investigators. Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease. Gut 2002;51:30-6. [PMID: 12077088 DOI: 10.1136/gut.51.1.30] [Cited by in Crossref: 168] [Cited by in F6Publishing: 147] [Article Influence: 8.0] [Reference Citation Analysis]
64 Taylor KD, Yang H, Rotter JI. Inflammatory bowel disease. II. Gene mapping. Mol Genet Metab 2001;74:22-44. [PMID: 11592801 DOI: 10.1006/mgme.2001.3214] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]